5-Bromo-1,2-dimethyl-1H-imidazole

Catalog No. :
ACKOYS097
CAS No. :
24134-09-6
Molecular Formula :
C5H7BrN2
Molecular Weight :
175.03

IUPAC Name:5-bromo-1,2-dimethyl-1H-imidazole

5-Bromo-1,2-dimethyl-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$74.00Login to see priceIn stockIn stock
25g97%$148.00Login to see priceIn stockIn stock
100g97%$543.00Login to see priceIn stockInquiry
500g97%$2063.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-1,2-dimethyl-1H-imidazole
IUPAC Name5-bromo-1,2-dimethyl-1H-imidazole
MDL No.MFCD06659905
Molecular FormulaC5H7BrN2
Molecular Weight175.03
SMILESCC1=NC=C(Br)N1C
InChI KeyWIRCWIXZNDCIST-UHFFFAOYSA-N
Synonym5-bromo-1,2-dimethyl-1H-imidazole | 24134-09-6 | 5-bromo-1,2-dimethylimidazole | MFCD06659905 | 1H-Imidazole, 5-bromo-1,2-dimethyl- | SCHEMBL303908 | DTXSID40428401 | WIRCWIXZNDCIST-UHFFFAOYSA-N | BCP26729 | ZAA13409 | AKOS006343260 | AB26592 | PS-3527 | SY020573 | AM20090265 | CS-003
CAS No.24134-09-6
PubChem CID7204879

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACKOYS097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOYS097 route product structure diagram
    ACKOYS09724134-09-6 In Stock
Inquiry

2. ACKOYS097 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEGFL619 route compound structure diagram
    ACEGFL61916265-11-5 In Stock
  4. Then
  5. ACKOYS097 route product structure diagram
    ACKOYS09724134-09-6 In Stock
Inquiry

Comments (0)